News Archive

April 2021

Implandata’s EYEMATE System Obtains FDA Breakthrough Device Designation

Implandata Ophthalmic Products, a digital health company with offices in Germany and San Diego, California has announced today that its game-changing EYEMATE system for digitally enabled remote patient monitoring and management of glaucoma has obtained Breakthrough Device Designation (BDD) from the U.S. Food and Drug Administration (FDA).

Read more …